Q Mark for Accessibility

ABLE Award

Q Mark for Accessibility

Q Mark for Accesibility

The ABLE award is a nationally recognised Quality Mark for accessibility in business. The ABLE award is given to organisations whose accessibility exceeds the standard required of current legislation

Jointly created by EIQA (Excellence Ireland Quality Association) and Failte Ireland. The ABLE Award is an acknowledgement of commitment to providing services to customers and staff who have a disability or who may acquire a disability in the future.

The ABLE Award provides the opportunity to improve current systems, processes and procedures whilst encouraging a new way of thinking about accessibility. The award creates an environment for learning and continuous improvement which benefits customers, employees and overall business model, while also demonstrating to customers and staff that Muscular Dystrophy Ireland has made a commitment to support equality, diversity and  accessibility.

The ABLE Award assesses services and facilities under three the following headings:

  • The ABLE Customer.
  • The Built Environment.
  • The ABLE Employee.

The ABLE Award focuses on improvements in the three key motivators to customer loyalty:

  • Great customer service.
  • Confident, happy staff.
  • Ease of accessibility

For more information ion the ABLE Award please contact The Excellence Ireland Quality Association at www.eiqa.com

Font Resize

1. Muscular Dystrophies

  • Becker muscular dystrophy
  • Duchenne muscular dystrophy
  • Manifesting carrier of Duchenne
  • Congenital muscular dystrophy - General
  • • MDC1A (merosin-deficient congenital muscular dystrophy)
  • • Rigid spine syndrome (RSS)
  • • Ullrich congenital muscular dystrophies
  • • Bethlem myopathy
  • Emery-Dreifuss muscular dystrophy

2. Myotonic Disorders

  • Congenital Myotonic Dystrophy
  • Myotonia
  • Myotonic Dystrophy

3. Congenital Myopathies

  • Central Core Myopathy
  • Minicore (Multicore) myopathy
  • Myotubular or Centronuclear myopathy
  • Nemaline myopathy

4. Mitochondrial Myopathies

  • Mitochondrial Myopathies

5. Metabolic Disorders

  • Metabolic disorders (general)
  • McArdle’s Disease
  • Pompe’s Disease

6. Periodic Paralyses

  • Periodic Paralyses

7. Autoimmune Myositides

  • Polymyositis, Dermatomyositis and Sarcoid myopathy
  • Juvenile dermatomyositis
  • Inclusion body myositis

8. Spinal Muscular Atrophies

  • Severe (Type I)
  • Intermediate (Type II)
  • Mild (Type III)
  • Adult spinal muscular atrophy

9. Hereditary Motor and Sensory Neuropathies

  • (Also known as Charcot-Marie-Tooth or Peroneal muscular atrophy)

10. Disorders of the Neuromuscular Junction

  • Congenital myasthenic syndromes
  • Myasthenia Gravis

11. Friedreich’s Ataxia

  • Facioscapulohumeral muscular dystrophy
  • Limb-girdle types of muscular dystrophy (LGMD) - General
  • • LGMD 1B (also known as Laminopathy)
  • • LGMD 1C (also known as Caveolinopathy)
  • • LGMD 2A (also known as Calpainopathy)
  • • LGMD 2B (also known as Dysferlinopathy)
  • • LGMD 2I
  • Ocular myopathies including ocularopharangeal muscular dystrophy

12. Other (Please Specify)

13. Unspecified